Global Enteric Softgel Market

Global Enteric Softgel Market Size, Share, Growth Analysis, By Type(Gelatin capsules and non-gelatin capsules), By Application(Health supplements and pharmaceuticals), By Distribution channel(Supermarkets and hypermarkets, pharmacies & drug stores) - Industry Forecast 2024-2031

Report ID: SQMIG35I2240 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 86 | Figures: 76

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Enteric Softgel Market size was valued at USD 2.4 billion in 2021 and is expected to rise from USD 2.5 billion in 2022 to reach a value of USD 3.48 billion by 2030 at the CAGR of 4.23% during the forecast period (2023-2030).

enteric softgel capsule market is competitive in nature due to the presence of prominent players. Major players increased their R&D investments to produce innovative products. Leading players adopted strategies such as merger, acquisitions, product launch, and others to strengthen their position in the market competition. Major players are focusing on the manufacturing of the non-gelatin capsules due to the rising vegan population in order to attract high revenues to their brand name. 'BASF SE', 'Catalent, Inc.', 'Colorcon Inc.', 'Fuji Capsules Co., Ltd.', 'InovoBiologic Inc.', 'NOW Foods Inc.', 'Sirio Pharma Co., Ltd.', 'Super Spectrim', 'Thermo Fisher Scientific, Inc. (Patheon)', 'Trigen Laboratories, Inc.', 'Aenova Group', 'ProCaps Laboratories', 'InovoBiologic Inc.', 'Lonza Group Ltd', 'NOW Foods Inc.', 'Nutranorth', 'Kaustubha Herbal & nutri Care', 'Vision Body Care Pvt.Ltd.', 'B N Herbals', 'United Laboratories'

Increasing investments in R&D to improve the bioavailability of these capsules is the major factor driving the market growth. Major players increased their production to meet the demand for healthy and nutritional supplements. For example, Catalent Pharma Solutions, an American player in the enteric softgel capsules market, recently announced that it will soon invest over USD 5 million in its new drug development center at its Somerset, New Jersey facility. This initiative will help the company improve its expertise in the capsule coating technology, ultimately helping it establish a stronger presence in the enteric softgel capsules market. Hence, the technologically advanced manufacturing methods and the presence of leading players in the market are focussed on reducing the overall complexity, cost, and drug development timelines that will ultimately improve the business efficiency and productivity.

A majority of the enteric softgel capsules involve the gelatin-based coatings, which is typically manufactured by using animal skin or bones. This makes it a non-vegetarian ingredient. Veganism is becoming the mainstream trend owing to the growing awareness about the negative impacts of the animal industry and increasing health concerns, coupled with the growing vegetarian consumers. It has significant impact on the dynamics of enteric softgel capsules market in the coming years.

North America is expected to dominate the global enteric softgel market during the forecast period. The growth of this region is attributed to high per capita healthcare expenditure, rising investments in R&D to develop novel variants, increasing consumer awareness about healthy and nutritional supplements. Major players such as Colocon Inc. dominate the North America market which help to fuel the demand for enteric softgel capsules in the coming years.

Related Reports

Morocco Medical Cannabis Market
Buy Now GET FREE SAMPLE
Vitamin K2 Market
Buy Now GET FREE SAMPLE
Global Otoplasty Market
Buy Now GET FREE SAMPLE
Mesotherapy Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Enteric Softgel Market

Product ID: SQMIG35I2240

$5,300
BUY NOW GET FREE SAMPLE